close

Rethinking death penalty during drug shortage

4 min read
article image -

COLUMBUS, Ohio – Ohio’s decision to delay executions another full year while it hunts for lethal injection drugs highlights an ongoing dilemma faced by the remaining death penalty states.

Although support for capital punishment continues, states are struggling to find a legal means to carry it out, and that has created an opening for opponents hoping to end the death penalty permanently.

“It really underscores the public’s growing distrust and dissatisfaction with state corrections departments being able to administer the death penalty,” Kevin Werner, who leads Ohioans to Stop Executions, said Tuesday.

Shortages and legal fights over drugs and their source are occurring in several states, among them Arkansas, Nebraska and Oklahoma. Yet capital punishment supporters say older methods such as hanging, electrocution and the firing squad are still viable options.

“We’ve got plenty of electric and plenty of rope,” said state Sen. Bill Seitz, a Cincinnati Republican.

On Monday, Ohio Gov. John Kasich used reprieves to push back 11 executions scheduled for next year and one in early 2017. Ohio now has 25 inmates scheduled to die, including some in 2019.

Ohio’s prison agency said it needs more time to find drugs. It hasn’t executed anyone since January 2014.

Death penalty supporters acknowledge the shortage could be the wedge in the door that leads to abolition of capital punishment. In central Ohio, Franklin County Prosecutor Ron O’Brien complains the state has “a functional moratorium” in place.

Nebraska has no way to execute inmates because it lacks two of the three required lethal injection drugs for its protocol. Voters will decide next year whether to keep a legislative repeal of capital punishment in place.

Like Ohio, Nebraska has looked overseas for execution drugs, which the Food and Drug Administration opposes. Two years ago, a federal appeals court ruled in a case brought by death row inmates in Tennessee, Arizona and California that the FDA was wrong to allow sodium thiopental to be imported for use in executions.

Congress could easily correct that ruling to allow such importation, said Kent Scheidegger, executive director of the California-based Criminal Justice Legal Foundation, which supports capital punishment.

“It is preposterous that well-deserved and already excessively delayed sentences are further delayed due to a completely artificial shortage of lethal injection drugs,” Scheidegger said.

Last week, the attorney general’s office in Oklahoma announced no executions will be scheduled until at least next year as the office investigates why the state used the wrong drug during a lethal injection in January and nearly did so again last month.

This month, an Arkansas judge halted executions of eight inmates who are challenging a law that allows the state to withhold any information that could publicly identify the manufacturers or sellers of its execution drugs.

On Oct. 1, Virginia executed serial killer Alfredo Prieto but only after obtaining pentobarbital from the Texas prison system. Texas has continued to purchase supplies of compounded pentobarbital without saying how much it has or where it came from.

Other death penalty states also are looking at alternatives to lethal injection. Tennessee passed a law last year to reinstate the electric chair if it can’t get lethal drugs, and Utah has reinstated the firing squad as a backup method.

Oklahoma approved nitrogen gas as an alternative method in April. But that’s just as flawed as lethal injection because it confuses medicine with punishment, said Robert Blecker, a New York Law School professor who favors capital punishment for the worst offenders.

Blecker, author of “The Death of Punishment: Searching for Justice Among the Worst of the Worst,” notes there has never been a botched execution by firing squad.

“How we kill those whom we rightfully detest should in no way resemble how we put to sleep beloved pets and how we anesthetize ourselves,” he said.

CUSTOMER LOGIN

If you have an account and are registered for online access, sign in with your email address and password below.

NEW CUSTOMERS/UNREGISTERED ACCOUNTS

Never been a subscriber and want to subscribe, click the Subscribe button below.

Starting at $3.75/week.

Subscribe Today